Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer
- PMID: 40022837
- DOI: 10.1016/j.ejca.2025.115323
Action plan for an international imaging framework for implementation of global low-dose CT screening for lung cancer
Abstract
Reduction in lung cancer mortality is achievable through low dose computed tomography (LDCT) screening in high-risk individuals. Many countries are progressing from local LDCT screening studies to national screening programs. Implementation of effective large-scale screening programs is complex and requires a multi-disciplinary approach. A recent overview of the technical aspects of implementing high quality LDCT for screening resulted from the inaugural international expert meeting of the Alliance for Global Implementation of Lung and Cardiac Early Disease Detection and Treatment (AGILE). This covers the most important aspects of the CT imaging process: standardisation in CT image acquisition and interpretation, CT protocol management, technology developments and minimal requirements, integration of lung cancer biomarkers, and the role of AI in CT lung nodule detection, segmentation, and classification, and related data security issues.
Keywords: Artificial intelligence; Biomarkers; Early detection; LDCT; Lung cancer; Lung nodule; Screening.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. M. Giger is contact PI for MIDRC and is on the editorial board for SPIE Journal of Medical Imaging. Dr. S. Fain serves as a scientific advisor for Polarean LLC. Dr. S. Fain also receives research funding from Polarean LLC, Siemens Healthineers INC, and GE Healthcare INC for development of pulmonary CT and MRI methods. Dr. K. Myers serves as a scientific and regulatory consultant for MIDRC, RevealDx, Annalise, and the I-ELCAP AIRS project funded by the Simons Foundation. All other authors have no competing interests to declare
Similar articles
-
Low-dose computed tomography lung cancer screening: Clinical evidence and implementation research.J Intern Med. 2022 Jul;292(1):68-80. doi: 10.1111/joim.13480. Epub 2022 Mar 24. J Intern Med. 2022. PMID: 35253286 Free PMC article. Review.
-
Lung Cancer Screening: Computed Tomography Radiation and Protocols.J Thorac Imaging. 2015 Sep;30(5):283-9. doi: 10.1097/RTI.0000000000000150. J Thorac Imaging. 2015. PMID: 25856411 Review.
-
Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer.J Thorac Oncol. 2024 Jan;19(1):36-51. doi: 10.1016/j.jtho.2023.07.019. Epub 2023 Jul 23. J Thorac Oncol. 2024. PMID: 37487906 Free PMC article. Review.
-
[China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2023 Version)].Zhongguo Fei Ai Za Zhi. 2023 Jan 20;26(1):1-9. doi: 10.3779/j.issn.1009-3419.2023.102.10. Zhongguo Fei Ai Za Zhi. 2023. PMID: 36792074 Free PMC article. Chinese.
-
The feasibility and cost-effectiveness of implementing mobile low-dose computed tomography with an AI-based diagnostic system in underserved populations.BMC Cancer. 2025 Feb 25;25(1):345. doi: 10.1186/s12885-025-13710-2. BMC Cancer. 2025. PMID: 40001094 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical